2025
SJR Q1
JCR Q2 · 4,7
649 matched articles
SCIE
Journal detail
Medical Oncology
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
135705601559131X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,963
- Quartile Q1
- H-Index 98
- Cites/doc 4,66
- Docs (3y) 910
- Cites (3y) 3.884
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,7
- 5Y JIF 4
- JCI 0,7
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Hematology Q2
- Medicine (miscellaneous) Q1
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,963 | 4,7 | 4 | 0,7 | Q2 | 98 |
| 2024 | Q1 | Q2 | 0,916 | 3,5 | 3,3 | 0,69 | Q2 | 95 |
| 2023 | Q2 | Q2 | 0,763 | 2,8 | 2,7 | 0,64 | Q3 | 95 |
| 2022 | Q2 | Q3 | 0,777 | 3,4 | 3,2 | 0,65 | Q3 | 95 |
| 2021 | Q2 | Q3 | 0,793 | 3,7 | 3,7 | 0,57 | Q3 | 95 |
| 2020 | Q1 | Q3 | 1,037 | 3,1 | 3,3 | 0,6 | Q3 | 95 |
| 2019 | Q1 | Q3 | 1,004 | 2,8 | 2,6 | 0,66 | Q3 | 95 |
| 2018 | — | Q2 | — | 3,3 | 2,6 | 0,7 | Q2 | — |
| 2017 | Q2 | Q3 | 0,757 | 2,9 | 2,7 | 0,67 | Q3 | 95 |
| 2016 | Q2 | Q3 | 0,832 | 2,6 | 2,5 | — | — | 95 |
| 2015 | Q1 | Q3 | 0,952 | 2,5 | 2,3 | — | — | 95 |
| 2014 | Q1 | Q3 | 1,006 | 2,6 | 2,4 | — | — | 95 |
| 2013 | Q1 | Q3 | 0,902 | 2,1 | 2 | — | — | 95 |
| 2012 | Q2 | Q3 | 0,701 | 2,1 | 2 | — | — | 95 |
| 2011 | Q2 | Q3 | 0,641 | 2,1 | 1,8 | — | — | 95 |
| 2010 | Q2 | Q3 | 0,603 | 2,2 | 1,8 | — | — | 95 |
| 2009 | — | Q4 | — | 1,2 | 1,2 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 1,2 | — | — | — |
| 2007 | — | Q4 | — | 1,4 | 1,2 | — | — | — |
| 2006 | — | Q4 | — | 1,3 | — | — | — | — |
| 2005 | — | Q4 | — | 1 | — | — | — | — |
| 2004 | — | Q4 | — | 1,2 | — | — | — | — |
| 2003 | — | Q4 | — | 1,2 | — | — | — | — |
| 2002 | — | Q3 | — | 1,4 | — | — | — | — |
| 2001 | — | Q3 | — | 1,3 | — | — | — | — |
| 2000 | — | Q3 | — | 1,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 97/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q2 | 106/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q3 | 157/322 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 125/241 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q3 | 144/245 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q3 | 180/242 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q3 | 148/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 104/230 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 127/223 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 126/217 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 130/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 118/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 136/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 118/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 117/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 110/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 134/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 132/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 110/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 110/127 |
| 2005 | ONCOLOGY | SCIE | Q4 | — | 110/123 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 98/123 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 98/120 |
| 2002 | ONCOLOGY | SCIE | Q3 | — | 76/114 |
| 2001 | ONCOLOGY | SCIE | Q3 | — | 77/107 |
| 2000 | ONCOLOGY | SCIE | Q3 | — | 67/103 |